Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
about
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic ComplicationsUncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a changeFacts and updates about cardiovascular non-coding RNAs in heart failureDiabetic Cardiomyopathy: Does the Type of Diabetes Matter?Diabetes and Clinical and Subclinical CVD.Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.Diagnostic approaches for diabetic cardiomyopathy.Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy.Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy.Constraints on Biological Mechanism from Disease Comorbidity Using Electronic Medical Records and Database of Genetic VariantsRelationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy PhenotypeSilent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic studyClinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsCardiac Computed Tomography Angiographic Findings as Predictors of Late Heart Failure in an Asymptomatic Diabetic Cohort: An 8-Year Prospective Follow-Up Study.Apigenin alleviates STZ-induced diabetic cardiomyopathy.Novel insight into the dangerous connection between diabetes and heart failure.Reframing the association and significance of co-morbidities in heart failure.Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.Coronary microvascular dysfunction in diabetes mellitus.MicroRNA and hyperglycemic memory in the diabetic heart.Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.Type 2 diabetes mellitus correlates with systolic function during myocardial stress perfusion scanning with Nitrogen-13 ammonia PET.Cathepsin K knockout protects against cardiac dysfunction in diabetic mice.Rutin administration attenuates myocardial dysfunction in diabetic rats.Metabolic cardiomyopathies - fighting the next epidemic.Role of Vitamin D in Cardiovascular Diseases.Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1.Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment-A Systematic Review.Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women?Comorbidities in Heart Failure.Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.Left atrium passive ejection fraction is the most sensitive index of type 2 diabetes mellitus-related cardiac changes.Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus.Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes.High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study.
P2860
Q26749552-9B1E3E1F-349D-4AFF-8025-3AF6A17EE88CQ26767122-A57A0FBB-9D34-4A8B-B20C-59644ED36B3FQ28072307-F4A84F89-E04E-4691-883A-A249487C416CQ28079593-F8DBA2A2-7477-4FAE-98AA-5C4072E7B08CQ30244573-1E94BB93-7ED2-4A2E-A8B5-EBB33592297EQ30250020-49B59E77-CD78-4C54-9489-1A837139B751Q30362092-7A22587A-E715-44F4-9A02-89BFF9E45D8EQ33660548-E22FCAD0-19B7-4487-924A-FA6383A6FBB3Q33781356-D1B709DD-1507-4B16-934A-663B20A79920Q33882472-FCCE9E61-80FB-4DE3-9590-CCA0EB23D499Q35999356-3473F558-1C24-45A3-B788-A5694A4FD7AAQ36070076-3FF2FD6C-29EB-40A9-8B6C-1873ED911212Q36205861-8F833CE0-C70A-47A7-95DB-046DBB848A3AQ37011769-92076978-31D4-4ADB-B67B-BCA116CD14D9Q38619761-2C2E8132-1662-4865-AA78-5DA2F5F6A233Q38717398-FC9259A1-0AFB-4AAB-A081-AA6FCAC7B054Q38806574-5B92EB8D-8D6C-4160-9F5B-2CDA24C20A6EQ38881287-7CEAC22B-EA07-4651-90D8-7EB3E2896516Q39201286-1FBD41B7-BF88-4F8D-B598-93E25849768CQ39393549-93F80547-C997-4456-A423-170435225523Q39716987-5B61E8A8-2CF8-494D-8D92-5B1305014CA4Q40420450-BAE3F14D-6789-49C2-978F-29F44BC03911Q41025346-3219C529-07F8-441E-BB32-AA51A0F81468Q41034679-6C2C4301-E4D2-485B-87EA-8AF9444ACCB4Q41310265-7488494F-5DD0-4579-8496-4C219EDF1700Q41458755-1FA3C03A-00DA-4AF2-AB43-D40C054D235DQ41713255-BEA16204-B23C-471C-B2D6-4A7CA53B2E3FQ42050369-87A0FE1F-115B-4DE6-9D99-0F96D2089706Q46209230-5813D530-F240-4B3E-AB6A-FD63B1F79555Q47122148-83151068-197C-4E6F-AC0F-CC311078361CQ47162150-CEB5E171-AABF-4ACF-AA86-326CB480ABBBQ47571604-47D49FB3-CE1D-44C0-9CEB-98E65CF1A568Q47744924-9B2EDAAD-6D63-45D7-9C6A-F063740C9C11Q47763435-38DC068F-DCA8-42A7-89A5-447BF38C7C53Q48105315-EB9300B3-8BB1-4C0E-A81D-DFF70C06D65AQ48207488-C6FFECF0-14F3-4742-91BC-D4DD61240EDDQ48247164-7B5E6D74-D3A0-4142-923D-0CCEC5E0DAAEQ49830046-3BEAF1CE-A769-4FE5-A988-0D3EA66BEA7AQ50100662-67787514-3B38-4D2D-A03C-A00029131ADEQ51735896-D6F5F2C7-313B-4FE2-959A-B351362C95A6
P2860
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical diabetic cardiomyopat ...... ictive and dilated phenotypes.
@en
type
label
Clinical diabetic cardiomyopat ...... ictive and dilated phenotypes.
@en
prefLabel
Clinical diabetic cardiomyopat ...... ictive and dilated phenotypes.
@en
P2860
P356
P1476
Clinical diabetic cardiomyopat ...... ictive and dilated phenotypes.
@en
P2093
Petar M Seferović
Walter J Paulus
P2860
P304
1718-27, 1727a-1727c
P356
10.1093/EURHEARTJ/EHV134
P577
2015-04-17T00:00:00Z